(Q37694527)

22 August 2017

1 reference

title

Current and emerging treatment strategies for cutaneous T-cell lymphoma (English)

1 reference

22 August 2017

0 references

Frederick Lansigan

1

1 reference

PubMed ID

20166766

22 August 2017

Francine M Foss

series ordinal

2

1 reference

22 August 2017

1 February 2010

1 reference

22 August 2017

1 reference

22 August 2017

70

1 reference

22 August 2017

3

1 reference

22 August 2017

273-286

1 reference

https://scigraph.springernature.com/pub.10.2165/11532190-000000000-00000

22 August 2017

0 references

cites work

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11532190-000000000-00000

Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11532190-000000000-00000

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

21 January 2018

1 reference

12 December 2020

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma

1 reference

12 December 2020

Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.

1 reference

12 December 2020

Topical mechlorethamine. Cutaneous changes in patients with mycosis fungoides after its administration

1 reference

12 December 2020

Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndrome

1 reference

12 December 2020

Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.

1 reference

12 December 2020

2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma

1 reference

12 December 2020

Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.

1 reference

12 December 2020

Photochemotherapy for cutaneous T cell lymphoma. A follow-up study

1 reference

12 December 2020

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

1 reference

12 December 2020

Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma

1 reference

12 December 2020

Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report

1 reference

12 December 2020

Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation

1 reference

12 December 2020

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome

1 reference

12 December 2020

Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sézary syndrome)

1 reference

12 December 2020

WHO-EORTC classification for cutaneous lymphomas

1 reference

12 December 2020

Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results

1 reference

12 December 2020

Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides

1 reference

12 December 2020

PUVA treatment of erythrodermic and plaque-type mycosis fungoides. Ten-year follow-up study

1 reference

12 December 2020

Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol

1 reference

12 December 2020

Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas

1 reference

12 December 2020

Narrowband UVB phototherapy for early-stage mycosis fungoides

1 reference

12 December 2020

T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement

1 reference

12 December 2020

[Significance of PUVA therapy for adult T-cell leukemia/lymphoma--PUVA therapy can induce apoptosis in leukemic cells]

1 reference

12 December 2020

A denileukin diftitox (Ontak) associated retinopathy?

1 reference

12 December 2020

Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma

1 reference

12 December 2020

Cutaneous T cell lymphoma: the helping hand of dendritic cells

1 reference

12 December 2020

Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma

1 reference

12 December 2020

Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome

1 reference

12 December 2020

Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy

1 reference

12 December 2020

Phototherapy and photopharmacology

1 reference

12 December 2020

Topical corticosteroids for mycosis fungoides. Experience in 79 patients

1 reference

12 December 2020

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

1 reference

12 December 2020

Total skin electron beam therapy in the management of mycosis fungoides

1 reference

12 December 2020

Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas

1 reference

12 December 2020

Photopheresis--extracorporeal irradiation of 8-MOP containing blood--a new therapeutic modality

1 reference

12 December 2020

Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma

1 reference

12 December 2020

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment

1 reference

12 December 2020

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

1 reference

12 December 2020

Retinoids in cutaneous T cell lymphomas

1 reference

12 December 2020

Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma

1 reference

12 December 2020

A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.

1 reference

12 December 2020

Pentostatin therapy of T-cell lymphomas with cutaneous manifestations

1 reference

12 December 2020

Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab

1 reference

12 December 2020

Probing the immune dysregulation in cutaneous T cell lymphomas

1 reference

12 December 2020

Total skin electron beam and total nodal irradiation of cutaneous T-cell lymphoma

1 reference

12 December 2020

Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma

1 reference

12 December 2020

Activity of Fludarabine Monophosphate in Patients With Advanced Mycosis Fungoides: A Southwest Oncology Group Study

1 reference

12 December 2020

Mycosis fungoides: management with topical nitrogen mustard

1 reference

12 December 2020

Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients

1 reference

12 December 2020

Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients

1 reference

12 December 2020

Histone deacetylase inhibitors

1 reference

12 December 2020

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

1 reference

12 December 2020

Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas

1 reference

12 December 2020

A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma

1 reference

12 December 2020

Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma

1 reference

12 December 2020

Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma

1 reference

12 December 2020

Interferon alfa-2a in the treatment of cutaneous T cell lymphoma

1 reference

12 December 2020

Anticancer activities of histone deacetylase inhibitors

1 reference

12 December 2020

2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders

1 reference

12 December 2020

Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

1 reference

12 December 2020

Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas

1 reference

12 December 2020

Combined modality therapy for cutaneous T-cell lymphoma

1 reference

12 December 2020

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

1 reference

12 December 2020

Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides

1 reference

12 December 2020

Interferon in the treatment of cutaneous T-cell lymphoma

1 reference

12 December 2020

Narrowband TL-01 phototherapy for patch-stage mycosis fungoides.

1 reference

12 December 2020

The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells

1 reference

12 December 2020

Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication.

1 reference

12 December 2020

The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sézary syndrome

1 reference

12 December 2020

The North American experience with photopheresis.

1 reference

12 December 2020

Optimal combination with PUVA: rationale and clinical trial update.

1 reference

12 December 2020

Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma

1 reference

12 December 2020

Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma

1 reference

12 December 2020

Drug evaluation: TG-1042, an adenovirus-mediated IFNgamma gene delivery for the intratumoral therapy of primary cutaneous lymphomas

1 reference

12 December 2020

Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma

1 reference

12 December 2020

Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma

1 reference

12 December 2020

10.2165/11532190-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

20166766

Dimensions Publication ID

22 August 2017

0 references

1 reference

PubMed ID

20166766